Relay Therapeutics Stock Increased 15% This Week

Relay Therapeutics (NASDAQ: RLAY) experienced a nearly 15% increase in its stock price during a holiday-shortened trading week, driven by a positive analyst note from Guggenheim Securities. Analyst Brad Canino initiated coverage with a buy rating and a price target of $15 per share, marking it as his firm’s Best Idea due to its substantial growth potential.

Want More Context? 🔎